SCHEMBL28570362

SCHEMBL28570362

CC(=O)Nc1ccc(S(=O)(=O)c2nc(Nc3cc(C)n[nH]3)cc(-c3ccc(OCCCN(C)C)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 2/20 0.43
▸ BPTF Q12830 1/20 0.41
▸ CECR2 Q9BXF3 1/20 0.41
▸ BRD9 Q9H8M2 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ ADORA2A P29274 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ IKBKB O14920 1/20 0.38
▸ JAK2 O60674 4/20 0.37
▸ HDAC6 Q9UBN7 4/20 0.37
▸ MOK Q9UQ07 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ HDAC1 Q13547 3/20 0.36
▸ ADORA3 P0DMS8 1/20 0.36
▸ KDR P35968 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28549342 0.87 ACHE (0.48) ACHEADORA2ALMNASMN1; SMN2ALDH1A1
SCHEMBL2202919 0.84 AURKB (0.53) RETADORA2AJAK2HDAC6MOK
SCHEMBL28557357 0.83 AURKB (0.49) BPTFADORA2ASMN1; SMN2ALDH1A1ADORA3
SCHEMBL28022063 0.80 SMN1; SMN2 (0.42) LMNASMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL28565368 0.79 AURKB (0.44) BPTFLMNASMN1; SMN2ALDH1A1TP53
SCHEMBL28556178 0.77 AURKA (0.39) SMN1; SMN2ALDH1A1TP53MAPT
SCHEMBL28021591 0.76 AURKB (0.51) ADORA2ALMNAALDH1A1ADORA3MAPT
SCHEMBL28022078 0.75 PKM (0.44) LMNAALDH1A1MAPT
SCHEMBL28021607 0.75 SLC2A1 (0.44) ACHELMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL28022048 0.75 AURKA (0.46) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112755193-A Method of treating malignancies with anti-tyrosine kinase inhibitors using dianhydrogalactitol or a derivative thereof 德玛医药 2021-05-07 — — CN disclosed
Send feedback